BioCentury
ARTICLE | Company News

Enzo sales and marketing update

November 22, 1993 8:00 AM UTC

Sales and service related revenues were $4.8 million in ENZ’s fourth quarter ended July 31, down slightly from $4.9 million in the quarter last year. ENZ sells diagnostics and DNA labeling and pathogen identification products in addition to providing clinical laboratory services. The quarter’s loss was $6.9 million (39 cents) vs. $1.3 million (9 cents). ...